CLBT
Cellebrite DI Ltd. trades as CLBT and has a market capitalization of $3.25 B, making it the #1743 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $475.68M, up 18.6% from the prior year and net income of $78.33M. This page tracks Cellebrite DI Ltd. through 319 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 6 fiscal years Cellebrite DI Ltd.'s revenue grew from $171.85M to $475.68M, a compound annual growth rate of 18.5%. Net profit margin expanded from -1.1% to 16.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider trade | 4 | 2026-05-19 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
First-Quarter ARR Growth of 21% and TTM Free Cash Flow Margin of 32%
Cellebrite Announces Participation in Upcoming Investor Conferences
Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2026 and discuss its 2026 outlook. Relevant details include:
The largest companies sharing Cellebrite DI Ltd.'s SEC industry classification (services-prepackaged software).
Cellebrite DI Ltd. (CLBT) has a market capitalization of $3.25 B as of 2026-06-10, ranking #1743 among US-listed companies.
Cellebrite DI Ltd. reported revenue of $475.68M for fiscal year 2025, an increase of 18.6% year over year.
Yes. Cellebrite DI Ltd. reported net income of $78.33M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.